Skip to content

Effect of nasal administration of hemp seed oil in sleep disturbance

“A randomized control trial to evaluate the efficacy of Vijaya Beej Tail Nasya in Anidra (Insomnia Disorder) ?

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044602
Enrollment
100
Registered
2022-08-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition

Interventions

None listed

Sponsors

Dr Gyanendra Datta Shukla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient fulfilling DSM-V criteria for insomnia disorder (non-comorbid). 2. Patient fit for Nasya procedure. 3. Patient does not have a history of hypersensitivity to the drug used

Exclusion criteria

Exclusion criteria: 1. Sleep-wake disorders other than Insomnia disorder like- Obstructive sleep apnea, Restless leg syndrome, Narcolepsy, Parasomnia, Circadian Rhythm disorder, REM sleep behaviour disorder, NREM Sleep arousal disorder. 2. Insomnia duration of less than a week (Transient Insomnia). 3. Patient having Insomnia along with any major chronic systematic disorder like- uncontrolled diabetes, uncontrolled hypertension, chronic pain, cancer, asthma, heart disease, GERD, Alzheimer’s disease, etc. 4. Patient having any major psychiatric disorder like- anxiety, depression, psychosis, schizophrenia, etc. 5. Patients taking medicines that can cause insomnia like - SSRI (antidepressants-Prozac and Zoloft), Dopamine agonist, anti-convulsant, B-agonist, theophylline, etc. 6. Severe alcoholics

Design outcomes

Primary

MeasureTime frame
1. APA level-2 sleep disturbance adult scale 2. Pittsburgh Sleep Quality Index (PSQI) 3. Ayurvedic parameters of Anidra/nidranash- i) Jrimbha (yawning) ii) Tandra (Drowsiness) iii) Angamarda (Body ache) iv) Bhram (Giddiness) v) Shiro Gaurav (Heaviness) vi) Jadyata (Stiffness) vii) Apakti (Indigestion) viii) Glani (Nausea)Timepoint: 4 time points: T1: Baseline (at the time of admission) T2: 10th day (after completion of 1st sitting of treatment) T3: 2oth day (after completion of 2nd sitting of treatment) T4:30th day (after completion of 3rd sitting of treatment)

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Mohita Bohra

Uttarakhand Ayurved University

mohita.india@gmail.com9456370494

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026